160 related articles for article (PubMed ID: 21346530)
21. Anatomic location of hyaluronic acid filler material injected into nasolabial fold: a histologic study.
Arlette JP; Trotter MJ
Dermatol Surg; 2008 Jun; 34 Suppl 1():S56-62; discussion S62-3. PubMed ID: 18547183
[TBL] [Abstract][Full Text] [Related]
22. Effect of monopolar radiofrequency treatment over soft-tissue fillers in an animal model: part 2.
Shumaker PR; England LJ; Dover JS; Ross EV; Harford R; Derienzo D; Bogle M; Uebelhoer N; Jacoby M; Pope K
Lasers Surg Med; 2006 Mar; 38(3):211-7. PubMed ID: 16485274
[TBL] [Abstract][Full Text] [Related]
23. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis.
Berlin AL; Hussain M; Goldberg DJ
Dermatol Surg; 2008 Jun; 34 Suppl 1():S64-7. PubMed ID: 18547184
[TBL] [Abstract][Full Text] [Related]
24. Use of high-frequency ultrasound in the assessment of injectable dermal fillers.
Young SR; Bolton PA; Downie J
Skin Res Technol; 2008 Aug; 14(3):320-3. PubMed ID: 19159378
[TBL] [Abstract][Full Text] [Related]
25. Granulomatous foreign-body reactions to permanent fillers: detection of CD123+ plasmacytoid dendritic cells.
Kadouch JA; Vos W; Nijhuis EW; Hoekzema R
Am J Dermatopathol; 2015 Feb; 37(2):107-14. PubMed ID: 25406851
[TBL] [Abstract][Full Text] [Related]
26. Clinical trial of a novel filler material for soft tissue augmentation of the face containing synthetic calcium hydroxylapatite microspheres.
Roy D; Sadick N; Mangat D
Dermatol Surg; 2006 Sep; 32(9):1134-9. PubMed ID: 16970693
[TBL] [Abstract][Full Text] [Related]
27. Adverse reactions caused by consecutive injections of different fillers in the same facial region: risk assessment based on the results from the Injectable Filler Safety study.
Bachmann F; Erdmann R; Hartmann V; Becker-Wegerich P; Wiest L; Rzany B
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):902-12. PubMed ID: 21054567
[TBL] [Abstract][Full Text] [Related]
28. [Granulomatous reactions from aesthetic dermal micro-implants].
Rongioletti F
Ann Dermatol Venereol; 2008 Jan; 135(1 Pt 2):1S59-65. PubMed ID: 18442665
[TBL] [Abstract][Full Text] [Related]
29. Poly-L-lactic acid: a temporary filler for soft tissue augmentation.
Woerle B; Hanke CW; Sattler G
J Drugs Dermatol; 2004; 3(4):385-9. PubMed ID: 15303782
[TBL] [Abstract][Full Text] [Related]
30. Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients.
Wiest LG; Stolz W; Schroeder JA
Dermatol Surg; 2009 Oct; 35 Suppl 2():1681-8. PubMed ID: 19807764
[TBL] [Abstract][Full Text] [Related]
31. Complications following injection of soft-tissue fillers.
Ozturk CN; Li Y; Tung R; Parker L; Piliang MP; Zins JE
Aesthet Surg J; 2013 Aug; 33(6):862-77. PubMed ID: 23825309
[TBL] [Abstract][Full Text] [Related]
32. Biocompatibility of microparticles into soft tissue fillers.
Laeschke K
Semin Cutan Med Surg; 2004 Dec; 23(4):214-7. PubMed ID: 15745227
[TBL] [Abstract][Full Text] [Related]
33. Survey of future injectables.
Ellis DA; Makdessian AS; Brown DJ
Facial Plast Surg Clin North Am; 2001 Aug; 9(3):405-11. PubMed ID: 11457704
[TBL] [Abstract][Full Text] [Related]
34. Injectable filler materials for soft-tissue augmentation.
Mak K; Toriumi DM
Otolaryngol Clin North Am; 1994 Feb; 27(1):211-22. PubMed ID: 8159423
[TBL] [Abstract][Full Text] [Related]
35. A randomized, prospective, blinded, split-face, single-center study comparing polycaprolactone to hyaluronic acid for treatment of nasolabial folds.
Galadari H; van Abel D; Al Nuami K; Al Faresi F; Galadari I
J Cosmet Dermatol; 2015 Mar; 14(1):27-32. PubMed ID: 25564797
[TBL] [Abstract][Full Text] [Related]
36. Treatment of injectable soft tissue filler complications.
Sclafani AP; Fagien S
Dermatol Surg; 2009 Oct; 35 Suppl 2():1672-80. PubMed ID: 19807763
[TBL] [Abstract][Full Text] [Related]
37. Facial dermal fillers: selection of appropriate products and techniques.
Dayan SH; Bassichis BA
Aesthet Surg J; 2008; 28(3):335-47. PubMed ID: 19083546
[TBL] [Abstract][Full Text] [Related]
38. Calcium hydroxylapatite filler: an overview of safety and tolerability.
Pavicic T
J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146
[TBL] [Abstract][Full Text] [Related]
39. Facial granulomas secondary to Dermalive microimplants: Report of a case with histopathologic differential diagnosis among the granulomas secondary to different injectable permanent filler materials.
Vargas-Machuca I; González-Guerra E; Angulo J; del Carmen Fariña M; Martín L; Requena L
Am J Dermatopathol; 2006 Apr; 28(2):173-7. PubMed ID: 16625084
[TBL] [Abstract][Full Text] [Related]
40. Complications of soft tissue augmentation.
Hirsch RJ; Stier M
J Drugs Dermatol; 2008 Sep; 7(9):841-5. PubMed ID: 19112797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
